1. Home
  2. MAIN vs STVN Comparison

MAIN vs STVN Comparison

Compare MAIN & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Main Street Capital Corporation

MAIN

Main Street Capital Corporation

N/A

Current Price

$58.28

Market Cap

4.8B

Sector

Finance

ML Signal

N/A

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$22.19

Market Cap

5.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAIN
STVN
Founded
2007
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Finance/Investors Services
Containers/Packaging
Sector
Finance
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
5.5B
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
MAIN
STVN
Price
$58.28
$22.19
Analyst Decision
Hold
Buy
Analyst Count
7
3
Target Price
$61.57
$25.67
AVG Volume (30 Days)
580.1K
443.3K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
8.04%
0.39%
EPS Growth
N/A
N/A
EPS
0.93
N/A
Revenue
N/A
N/A
Revenue This Year
$6.27
$9.67
Revenue Next Year
$5.14
$9.99
P/E Ratio
$62.55
$27.15
Revenue Growth
N/A
N/A
52 Week Low
$48.95
$12.89
52 Week High
$67.26
$28.00

Technical Indicators

Market Signals
Indicator
MAIN
STVN
Relative Strength Index (RSI) 62.02 67.99
Support Level $54.60 $20.34
Resistance Level $59.55 $24.01
Average True Range (ATR) 1.17 0.73
MACD -0.05 0.08
Stochastic Oscillator 74.99 98.68

Price Performance

Historical Comparison
MAIN
STVN

About MAIN Main Street Capital Corporation

Main Street Capital Corp is a principal investment firm focused on providing customized long-term debt and equity capital solutions to lower middle market ("LMM") companies and debt capital to private ("Private Loan") companies owned by or in the process of being acquired by a private equity fund. The group invests principally in secured debt investments, equity investments, warrants, and other securities of LMM companies, typically based in the U.S. The company operates as a single segment with a principal investment objective to maximize total return by generating current income from debt investments and current income and capital appreciation from equity and equity-related investments.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

Share on Social Networks: